MTOR and autoimmune polyendocrinopathy: IgG antibodies from APS patients, when incubated with vascular endothelial cells, stimulate the mammalian/mTOR through the phosphatidylinositol 3-kinase–AKT pathway (120) leading to cell proliferation.